Latest disclosed round
Series B
- Date
- 2022-01-01
- Amount
- USD 100m
- Sector
- Deeptech / hardware
- Companies House
- 09757696
Series B
Ori Biotech
Cell & gene therapy manufacturing hardware
VerifiedSeries BLondon
Evidence status
Directory ready
- Identity
- Verified
- Match
- Verified
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
4 linked investors
Funding record
3 disclosed rounds
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2022-01-01 | Series B | $100m+ | Novalis LifeSciences, Puhua Capital, Chimera Abu Dhabi |
| 2020-10-14 | Series A | $30M | Northpond Ventures, Octopus Ventures, Amadeus Capital Partners, Delin Ventures, Kindred Capital |
| 2020-01-09 | Seed | $9.4M (£7M) | Amadeus Capital Partners, Delin Ventures, Kindred Capital, a London-based family office, an angel investor group |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.